Extrapyramidal Disorders (Disease Or Phenotype)

Omim:MTHU012544

Nci:C79593

Msh:D001480

Mondo:MONDO:3996

Medcin:MEDCIN:210090

Mdr:MDR:10042804

Id:b9a4afdd-a1c2-5102-b3f8-64f1fa8b4efc

Icpc2icd10eng:MTHU072709

Efo:EFO:9533

Doid:DOID:679

Chv:CHV:4801

Linked to

	Label	Description
	Adamantan-1-ylamine indication Extrapyramidal Disorders Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Trihexyphenidyl indication Extrapyramidal Disorders Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	benzatropine indication Extrapyramidal Disorders Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	biperiden indication Extrapyramidal Disorders Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Adamantan-1-ylamine indication Extrapyramidal Disorders

A Knowledge Graph Assertion from IDG

Trihexyphenidyl indication Extrapyramidal Disorders

A Knowledge Graph Assertion from IDG

benzatropine indication Extrapyramidal Disorders

A Knowledge Graph Assertion from IDG

biperiden indication Extrapyramidal Disorders

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025